2015 Executive Compensation Schedule for NewLink Genetics Corporation
Contract Categories:
Human Resources
›
Compensation Agreements
Summary
This document outlines the 2015 compensation details for four executives at NewLink Genetics Corporation. It specifies each executive's base salary, target bonus as a percentage of salary, and the number of stock options and restricted stock units awarded. The agreement sets out the compensation structure for the Chairman/CEO, President/CMO, Clinical and Regulatory Affairs Officer, and VP of Business Development for the year 2015.
EX-10.2 3 nlnk-20150106x8kxex102.htm EXHIBIT - 2015 NLNK-20150106-8K-EX10.2
Exhibit 10.2
2015 Salaries, Bonus Targets and Equity Awards | |||||||
Name and Title | 2015 Salary | Bonus Target* | Stock Options | Restricted Stock Unit Awards | |||
Charles J. Link, Jr., M.D. | $640,700 | 60 | % | 143,000 | 45,000 | ||
Chairman of the Board and Chief | |||||||
Executive and Scientific Officer | |||||||
Nicholas N. Vahanian, M.D. | $531,800 | 50 | % | 81,000 | 25,000 | ||
President and Chief Medical Officer | |||||||
W. Jay Ramsey, M.D., Ph.D. | $345,800 | 35 | % | 24,800 | 7,800 | ||
Clinical and Regulatory Affairs Officer | |||||||
Brian Wiley | $319,600 | 30 | % | 23,400 | 7,400 | ||
Vice President of Business Development | |||||||
* Bonus Targets listed as percentage of 2015 Base Salary | |||||||